Patients Stopping Anti-Obesity Jabs Regain Weight at a Quadrupled Rate Compared to Dieters

Fresh analysis reveals that individuals who come off popular slimming jabs like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who end traditional diet and exercise regimens.

Published data in a major health publication points out that while obese individuals often shed substantial amounts of their body weight while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month once they quit.

"Users purchasing such drugs need to be informed of the potential of quick weight regain when the treatment ends," stated expert Dr. Susan Jebb.

That rate of recovery implies a return to starting mass in about one and a half years.

Weighing Treatments

The study, which reviewed 37 of trials involving thousands of patients, compared the effects of these new drugs with older methods.

Researchers note that individuals who lose weight through diet and exercise usually experience a less rapid creep back—approximately 0.1 kg a month—once they finish.

Explaining the Quick Regain

Nutrition scientists believe the mode of action of the injections accounts for the amplified rebound.

The injections copy a body's own chemical called GLP-1, which controls appetite.

"Artificially providing GLP-1 concentrations far above than the body's typical production could lead to the system to generate a reduced amount of its own natural hormone, and could diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.

"Stopping of this medication means appetite is unsuppressed, making excessive eating far more likely."

An Ongoing Condition?

Health authorities advise the injections for people with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.

Professionals argue that, given the high risk of relapse, the treatment should be considered ongoing.

This view is supported by drug manufacturers, who say that the results "underscore the chronic character of excess weight," similar to managing diseases like high blood pressure.

User Testimonies

Users who have stopped the medication describe a intense return of appetite.

"It felt as if something that goes on and you become ravenous," described an individual.

This difficulty is worsened if individuals have not developed lasting dietary or behavioural modifications during treatment.

Widespread Interest

Survey data indicate that millions of people in the UK have tried these injections in the past year, with interest being substantial.

• Use is higher among women compared to men.
• The 40s and 50s age group shows the greatest level of interest.
• Many obtain the drugs through private healthcare rather than public health services.

Finally, researchers caution that while the jabs are potent tools for shedding pounds, they are not a magic fix and maintained weight loss hinges on combined lifestyle management.